34 studies found for:    Lyme disease | "Borrelia Infections"
Show Display Options
Rank Status Study
21 Unknown  Doxycycline in Therapy of Erythema Migrans
Condition: Lyme Borreliosis
Intervention: Drug: Doxycycline
22 Not yet recruiting Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
Condition: Neuroborreliosis, Borrelia Burgdorferi
Interventions: Drug: Doxycycline;   Drug: Placebo
23 Recruiting Study on Early Lyme Neuroborreliosis
Condition: Nervous System Lyme Borreliosis
Intervention: Drug: ceftriaxone
24 Completed Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
Conditions: Relapsing Fever, Tick-Borne;   Jarisch Herxheimer Reaction
Intervention: Drug: doxycycline treatment
25 Completed Phase 1/2 Lyme Vaccine Study
Condition: Prophylaxis of Lyme Borreliosis
Intervention: Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine
26 Unknown  Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
Condition: Suspected Early Lyme Neuroborreliosis
Interventions: Drug: doxycycline;   Drug: ceftriaxone
27 Recruiting Antibiotic Treatment of Multiple Erythema Migrans
Condition: Multiple Erythema Migrans
Interventions: Drug: ceftriaxone;   Drug: doxycycline;   Other: erythema migrans patients treated with doxycycline
28 Recruiting Cytokines and Chemokines in Erythema Migrans
Condition: Erythema Migrans
Intervention: Drug: antibiotic treatment
29 Completed
Has Results
Duration of Antibiotic Treatment of Erythema Migrans
Condition: Erythema Chronicum Migrans
Interventions: Drug: doxycycline;   Drug: placebo
30 Not yet recruiting Study of Lyme Neuroborreliosis
Condition: Lyme Neuroborreliosis
Interventions: Drug: Doxycycline;   Drug: Ceftriaxone
31 Completed Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
Condition: Lyme Neuroborreliosis
Interventions: Drug: Ceftriaxone;   Drug: Doxycycline
32 Recruiting Laboratory Characteristics in Chronic Atrophic Acrodermatitis
Condition: Chronic Atrophic Acrodermatitis
Interventions: Drug: doxycycline orally, 100 mg, bid, 14 days;   Drug: doxycycline orally, 100 mg, bid, 28 days
33 Active, not recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
Conditions: Visceral Leishmaniasis;   Human African Trypanosomiasis;   Enteric Fever;   Melioidosis;   Brucellosis;   Leptospirosis;   Relapsing Fever;   Rickettsial Diseases;   HIV;   Tuberculosis;   Malaria;   Amoebic Liver Abscess
Interventions: Device: rk28 ICT;   Device: IT LEISH (rK39);   Device: Immunochromatographic HAT test;   Device: HAT Serostrip;   Device: Card Agglutination Trypanosoma Test (CATT)-10;   Device: Typhidot M;   Device: S. typhi IgM/IgG;   Device: Test-it Typhoid IgM;   Device: Test-it Leptospirosis IgM;   Device: Leptospira IgG/IgM
34 Completed Microbiologic Findings of Acute Facial Palsy in Children
Condition: Facial Paralysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-34) Next Page   
Indicates status has not been verified in more than two years